PARKINSON DISEASE (Disorder)
Neurology·MeSH: Parkinson Disease
Prevalence
150.0 / 100K
Incidence
15.0 / 100K/yr
1 drug in development·1 company·5 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| ser-252 | Serina Therapeutics, Inc. (SER) |
Frequently asked questions
How many drugs are in development for PARKINSON DISEASE (Disorder)?
BioSniper tracks 1 drug in development for PARKINSON DISEASE (Disorder) across 1 company.
How many clinical trials target PARKINSON DISEASE (Disorder)?
There are 5 clinical trials targeting PARKINSON DISEASE (Disorder) tracked by BioSniper.
What is the prevalence of PARKINSON DISEASE (Disorder)?
The estimated prevalence of PARKINSON DISEASE (Disorder) is approximately 150.0 per 100,000 population.
Deep-dive into PARKINSON DISEASE (Disorder)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis